This multi-pathway model builds on existing GLP-1 and dual-agonist therapies such as semaglutide and tirzepatide but extends their metabolic benefits
Soothe thirsty skin, improve uneven tone, and brighten dull skin with this vitamin E and C rich formula
GLP-1 is a hormone your body naturally produces in the gut
Among these emerging compounds, Cagrilintide stands out for its promising synergy when paired with agents like semaglutide and tirzepatide
This development comes after the MHRA, the organisation responsible for approving new medicines in the UK, approved the new Wegovy 7.2mg dose in January 2026
Scientific interest in Melanotan II continues to expand due to its utility in studies involving melanocortin-associated signaling networks, receptor-mediated communication, and neuropeptide regulatory mechanisms